The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
Open accessAbstract
Multiple sclerosis (MS) is one of the world's most common neurologic disorders, and in many countries it is the leading cause of nontraumatic neurologic disability in young adults. Despite this, global information on the epidemiology of MS and the availability of resources and services for people with MS is scarce in many regions of the world. The first Atlas of MS , published in 2008 as a joint project of the Multiple Sclerosis International Federation (MSIF) and the World Health Organization (WHO),1 endeavored to fill this knowledge gap with information from 112 countries. Here, we outline important updates in the recently launched Atlas of MS 2013: Mapping Multiple Sclerosis around the World. 2 The authors thank Bernard Uitdehaag, PhD (VU University Medical Center, the Netherlands); Ed Holloway (Multiple Sclerosis Society, UK); Lekha Pandit, MD, PhD (Nitte University, India); and Mario Battaglia, MD (Associazione Italiana Sclerosi Multipla, Italy) of the MSIF Atlas of MS Study Group Committee who developed the templates used to collect the data for this manuscript.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The MS International Federation compiled an international atlas of the epidemiology of multiple sclerosis with detailed country-level data, but did not use systematic modelling for disease morbidity, mortality, and risk factors.
“The MS International Federation has compiled a useful international atlas of the epidemiology of multiple sclerosis with detailed country-level data, but this group did not use systematic modelling for disease morbidity, mortality, and risk factors.10”
From Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) · cites this paper as [10]
The main text (page not provided) says MSIF acquired data from 104 countries and mapped their distribution by country, supporting the atlas and country-level data portion of the claim. It describes compilation and calculation, but does not establish that the group did not use systematic modelling for morbidity, mortality, and risk factors; searches for those modelling terms found no decisive passage. (LLM, conf=0.82)
Experimental — accuracy not yet measuredPatients with multiple sclerosis experience associated symptoms including depression, anxiety, stress, fatigue, and pain.
“Persons with MS (PwMS) in addition to losing motor, sensory, and cognitive functions, also experience associated symptoms including depression, anxiety, stress, fatigue, andpain(2, 3).”
From The Effectiveness of Cognitive-Behavioral, Mindfulness and Acceptance and Commitment Therapies to Improving the Psychological Symptoms of Patients with Multiple Sclerosis in Iran (Systematic Review and Meta-analysis) (2022) · cites this paper as [2]
The paper’s main text discusses MS-related disability and access to therapies for symptoms, but does not identify depression, anxiety, stress, fatigue, or pain as symptoms experienced by people with MS. Searches for the symptom list and a paraphrase found no passage addressing those specific symptoms; the copy is not truncated. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Convention on the Rights of Persons with Disabilities
Myhill, W. N. (2014) · Encyclopedia of Human Services and Diversity · doi:10.4135/9781483346663.n124 · Cited by 2,158
Convention on the Rights of Persons with Disabilities
Nations, U. (2009) · Jahrbuch für Wissenschaft und Ethik · doi:10.1515/9783110208856.203 · Cited by 849
United Nations Convention on the Rights of Persons With Disabilities
Rasmussen, M., & Lewis, O. (2007) · International Legal Materials · doi:10.1017/s0020782900005039 · Cited by 672
Design and implementation of home automation system
Alheraish, A. (2004) · IEEE Transactions on Consumer Electronics · doi:10.1109/tce.2004.1362503 · Cited by 314
Fox, R. J., Thompson, A. J., Baker, D., Baneke, P., Brown, D., Browne, P., Chandraratna, D., Ciccarelli, O., Coetzee, T., Comı, G., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512458169 · Cited by 117
Self-citation
Flagged first, then by citations
Research works printed but not linked: 4
- Atlas: Multiple Sclerosis Resources in the World 2008. Geneva, Switzerland: World Health Organisation; 2008. Available at: http://www.msif.org/about-ms/publications-and-resources/. Accessed October 10, 2013.
- Atlas of MS 2013: Mapping Multiple Sclerosis Around the World. London: Multiple Sclerosis International Federation; 2013. Available at: http://www.msif.org/about-ms/publications-and-resources/. Accessed October 10, 2013.
- Principles to Promote the Quality of Life of People with Multiple Sclerosis. London: Multiple Sclerosis International Federation; 2005. Available at: http://www.msif.org/about-ms/publications-and-resources/. Accessed October 10, 2013.
- MS Barometer 2011. Brussels: European Multiple Sclerosis Platform; 2011. Available at: http://www.emsp.org/projects/ms-id/160-ms-barometer-2011. Accessed October 10, 2013.
Cited by
Sorted by citations
Wallin, M. T., Culpepper, W. J., Nichols, E., Bhutta, Z. A., Gebrehiwot, T. T., Hay, S. I., Khalil, I. A., Krohn, K. J., Liang, X., Naghavi, M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30443-5 · Cited by 1,134
Treatment of Multiple Sclerosis: A Review
Hauser, S. L., & Cree, B. A. C. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.05.049 · Cited by 969
“(2) B cell rich lymphoid aggregates in the meninges, often in deep sulci, with underlying cortical demyelination and neuronal loss.”
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
Ontaneda, D., Thompson, A. J., Fox, R. J., & Cohen, J. A. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31320-4 · Cited by 298
Self-citationNRF2 as a Therapeutic Target in Neurodegenerative Diseases
Brandes, M. S., & Gray, N. E. (2020) · ASN Neuro · doi:10.1177/1759091419899782 · Cited by 297
Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases
Ciregia, F., Urbani, A., & Palmisano, G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00276 · Cited by 110
The impact of disease characteristics on multiple sclerosis patients’ quality of life
Rezapour, A., Almasian Kia, A., Goodarzi, S., Hasoumi, M., Nouraei Motlagh, S., & Vahedi, S. (2017) · Epidemiology and Health · doi:10.4178/epih.e2017008 · Cited by 80
Microglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
Pentón-Rol, G., Marín-Prida, J., & McCarty, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210408123807 · Cited by 73
Diagnosis and Management of Progressive Multiple Sclerosis
Macaron, G., & Ontaneda, D. (2019) · Biomedicines · doi:10.3390/biomedicines7030056 · Cited by 70
Social support in multiple sclerosis: associations with quality of life, depression, and anxiety
Ratajska, A., Glanz, B. I., Chitnis, T., Weiner, H. L., & Healy, B. C. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110252 · Cited by 66
Giovannetti, A. M., Quintas, R., Tramacere, I., Giordano, A., Confalonieri, P., Messmer Uccelli, M., Solari, A., & Pakenham, K. I. (2020) · PLOS ONE · doi:10.1371/journal.pone.0231380 · Cited by 53
Hyarat, S. Y., Subih, M., Rayan, A., Salami, I., & Harb, A. (2019) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2018.08.006 · Cited by 51
Doss, P. M. I. A., Umair, M., Baillargeon, J., Fazazi, R., Fudge, N., Akbar, I., Yeola, A. P., Williams, J. B., Leclercq, M., Joly-Beauparlant, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108833 · Cited by 39
Riemann-Lorenz, K., Motl, R. W., Casey, B., Coote, S., Daubmann, A., & Heesen, C. (2021) · Disability and Rehabilitation · doi:10.1080/09638288.2020.1731612 · Cited by 30
Shkodina, A. D., Bardhan, M., Chopra, H., Anyagwa, O. E., Pinchuk, V. A., Hryn, K. V., Kryvchun, A. M., Boiko, D. I., Suresh, V., Verma, A., et al. (2024) · CNS Drugs · doi:10.1007/s40263-024-01072-5 · Cited by 31
Han, A. (2021) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2021.03.011 · Cited by 29
Evers, I., Heerings, M., de Roos, N. M., Jongen, P. J., & Visser, L. H. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1885240 · Cited by 26
Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis
Ojeda-Hernández, D. D., Hernández-Sapiéns, M. A., Reza-Zaldívar, E. E., Canales-Aguirre, A., Matías-Guiu, J. A., Matías-Guiu, J., Mateos-Díaz, J. C., Gómez-Pinedo, U., & Sancho-Bielsa, F. (2022) · Life · doi:10.3390/life12091417 · Cited by 25
Omura, S., Sato, F., Martinez, N. E., Park, A.-M., Fujita, M., Kennett, N. J., Cvek, U., Minagar, A., Alexander, J. S., & Tsunoda, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00516 · Cited by 20
MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis
Asl, E. R., Hosseini, S. E., Tahmasebi, F., Bolandi, N., & Barati, S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01578-6 · Cited by 19
Heidari‐Soureshjani, R., Nasrabadi, A. N., Zakerimoghadam, M., Mohammadi, T., & Rasti, A. (2023) · Health Science Reports · doi:10.1002/hsr2.1536 · Cited by 10
Ucar, E. A., Ozkan, E., Shomalizadeh, N., Sekerdağ-Kilic, E., Akpunar, F., Sapanci, S., Kesibi, J., Ozler, C., Bilgez, A. S., & Gursoy-Ozdemir, Y. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1403974 · Cited by 5
Bahmani, B., Mehraban, S., Azkhosh, M., Khanjani, M. S., & Azimian, M. (2022) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-127590 · Cited by 2
Goldsmith, K., Hudson, J. L., Chalder, T., Dennison, L., & Moss-Morris, R. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103594 · Cited by 2
Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers
Kaisey, M., Solomon, A. J., Luu, M., Giesser, B. S., & Sicotte, N. L. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.01.048 · Cited by 148
Metadata
- Authors
- Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B. V., & Thompson, A. J.
- Affiliations
- University of Tasmania (AU)
- Venue
- Neurology
- Published
- 2014-09-09
- Volume
- 83
- Issue
- 11
- Pages
- 1022-1024
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC4162299
- OpenAlex
- W2027285375
- Cited by
- 1,223
- References
- 5
- Citations by year
- 2026: 34 · 2025: 74 · 2024: 99 · 2023: 115 · 2022: 113 · 2021: 159 · 2020: 194 · 2019: 157 · 2018: 140 · 2017: 81 · 2016: 36 · 2015: 21
- FWCI
- 34.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Associazione Italiana Sclerosi Multipla
- Multiple Sclerosis Society
- Vrije Universiteit Amsterdam
- Multiple Sclerosis International Federation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- multiple sclerosis, global health inequities, health service availability, neurodisability, young adults, World Health Organization
- MeSH terms
- Atlases as Topic, Health Services Accessibility, Humans, Multiple Sclerosis, Poverty Areas, Self-Help Groups, Global Health, Prevalence, Internet, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
